ENMC

What ENMC does

ENMC (European Neuromuscular Centre) is a Netherlands-based non-profit organization founded in 1992 by a group of European patient associations. It operates an international network that supports neuromuscular disease research by organizing and financing small, application-driven workshops that bring together leading researchers, clinicians, and patient representatives from more than 75 countries. Topics span outcome measures, clinical trial readiness, preclinical studies, diagnosis, and standards of care across rare neuromuscular disorders.

The organization's core offering is its workshop format, supplemented by themed workshops prioritized by stakeholders, an Early-Career Programme, a Mid-Career Mentoring Programme, structured Patient Participation initiatives, and a Company Forum for pharmaceutical and biotechnology sponsors. Workshop outputs are documented in lay reports, clinical guidelines, and scientific publications, with over 90% of results published in the journal Neuromuscular Disorders (Elsevier); more than 290 workshops have been hosted since 1992. The active network comprises over 5,000 researchers, clinicians, and patients.

ENMC does not sell products or services in the commercial sense. Its operating model relies on partner organizations, workshop co-sponsors, Company Forum membership fees, and stakeholder contributions. Headquarters are in Baarn, Netherlands, with a lean staff of 1-10 employees, and the company has no parent organization, subsidiaries, or public-market listing. Recent activity in 2025-2026 has added new pharma partners (argenx, Avidity Biosciences) and patient organizations (FSHD Europe) to the network, and introduced a themed workshop format aligned with emerging gene therapy research priorities.

Name

ENMC

Legal name

European Neuromuscular Centre

Website

https://enmc.org

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

1–10 employees

Short description

ENMC is a Netherlands-based non-profit, founded in 1992, that organizes and finances international workshops to connect over 5,000 researchers, clinicians and patient representatives working on rare neuromuscular diseases across 75+ countries.

Ownership category

akta.pro rank

Product category

Neuromuscular Disease Research Collaboration Services

NAICS

Business Associations (813910), Convention and Trade Show Organizers (561920), Business, Professional, Labor, Political, and Similar Organizations (8139)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Association & Society Conference Management (Nonprofit, Professional Bodies) (THAHACAA)

Keywords

• Neuromuscular disease research
• Scientific workshop facilitation
• Rare disease collaboration
• Clinical trial readiness
• Patient participation programs

Headquarters

HQ city

Baarn

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Distribution channels1 record

Marketing channels4 records

Core offering

ENMC is a non-profit foundation that organises and finances international workshops on an application basis, bringing together leading neuromuscular researchers, clinicians and patient representatives to collaborate on outcome measures, clinical trial readiness, preclinical studies, diagnosis and standards of care. Its core deliverable is curated, multi-stakeholder workshop programs (including themed and open workshops), complemented by structured early-career and mid-career mentoring programs, patient participation initiatives and published workshop reports and guidelines.

Product overview

ENMC (European Neuromuscular Centre) is a non-profit organization that operates as a network facilitating international collaboration in neuromuscular research. The organization does not offer a software product but rather provides a platform of services centered around organizing and financing workshops that bring together researchers, clinicians, and patient representatives from over 75 countries. The core offerings include themed workshops on prioritized research topics, open workshops on applicant-proposed topics, early-career programs, mid-career mentoring, patient participation initiatives, and a Company Forum for industry collaboration. ENMC publishes workshop results in Neuromuscular Disorders journal and maintains an active network of over 5,000 researchers, clinicians, and patients.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• More than 290 workshops hosted since 1992
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered minor and core.

• argenxminorGTM or Marketing Partner · 8 April 2026argenx joined the ENMC Company Forum in 2026 as a new member. The Company Forum brings together pharmaceutical and biotech companies supporting neuromuscular research.
• Avidity BiosciencesminorGTM or Marketing Partner · 8 April 2026Avidity Biosciences joined the ENMC Company Forum in 2026 as a new member. The Company Forum is a group of companies that support ENMC's mission.
• FSHD EuropecoreStrategic or Co-development Partner · 18 March 2026FSHD Europe joined as an ENMC Associated Partner in March 2026, expanding the network of patient organizations connected to ENMC's research activities.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• World Muscle Society (WMS): WMS is the leading international professional society for neuromuscular specialists, organizing scientific congresses and publishing research — the closest peer in terms of scientific-convening and publication role, but with a professional-society rather than workshop-funder model.
• Muscular Dystrophy Association (MDA): MDA is a major US-based non-profit that funds neuromuscular disease research, supports patients and families, and convenes clinicians — closely aligned with ENMC's mission of accelerating research and care for neuromuscular disorders.
• Muscular Dystrophy UK: Muscular Dystrophy UK is a UK-based charity funding neuromuscular research and supporting affected families — directly comparable in disease focus, research funding role, and patient advocacy to ENMC.
• Treat-NMD Alliance: Treat-NMD is a European network that coordinates neuromuscular disease research, standards of care, and trial readiness across countries — the closest direct analogue to ENMC's convening and consortium-building function in the same disease area.
• FSHD Society: FSHD Society is a global research and patient organization dedicated to facioscapulohumeral muscular dystrophy; directly comparable as a neuromuscular-specific non-profit engaged in research facilitation and consortia-building.
• Charcot-Marie-Tooth Association (CMTA): CMTA is a US-based patient-led non-profit funding research and convening clinicians around Charcot-Marie-Tooth disease — a peer in disease-specific non-profit research facilitation and clinical-trial-readiness activities within the broader neuromuscular space.
• Cure SMA: Cure SMA is a US-based non-profit focused exclusively on spinal muscular atrophy research, drug development, and patient support — a disease-specialist peer with a comparable funding-plus-convening model for a subset of neuromuscular disorders.
• Parent Project Muscular Dystrophy (PPMD): PPMD is a US non-profit focused on Duchenne muscular dystrophy research, advocacy, and care — a disease-specialist peer with comparable functions in research funding, patient participation, and clinical trial readiness for the DMD/BMD subset.
• AFM-Téléthon: AFM-Téléthon is the leading French neuromuscular disease association, funding research and running patient-centric programs — a peer in mission and disease focus, though with a stronger national fundraising and service-delivery orientation.
• European Reference Networks (ERN) - EURO-NMD: EURO-NMD is the European Reference Network for rare neuromuscular diseases, coordinating clinical expertise and research across European centers — comparable in cross-border convening role and disease focus, though structured as an EU-funded healthcare network rather than an independent non-profit.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks1 record

Key highlights7 records

Customer concentration

• Xx.com/_enmc
• LinkedInlinkedin.com/company/european-neuromuscular-centre

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ENMC